The Chronic Drugs Medical Scheme (CDMS) is a social entrepreneurship established to develop and implement innovative supply chain interventions to reduce the cost of chronic illness medication, in order to improve access and affordability for low income Kenyans particularly those living on less than the equivalent of $2 Purchasing Power Parity (PPP) per day.
Low income Kenyans rely on the public health system for their health needs, as they cannot afford the high costs in private hospitals and chemists. However challenges in the public health system means that services are not often readily accessible, especially in the availability of essential drugs. Patients are thus compelled to turn to these private facilities. The end result is that many individuals go without medication or buy inadequate dosages, in either case resulting in poor health outcomes.
CDMS therefore targets small private hospitals and chemists who, because of working capital and space limitations buy drugs in small quantities thus not being able to qualify for quantity discounts. By being able to deliver lower procurement costs to these facilities, CDMS aims to lower the end user prices of drugs thus supporting one of the key pillars for achieving Sustainable Development Goal (SDG) number 3-“Good Health & Wellbeing”.